微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 0.73% | -86.23% | 48.98% | 112/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | 0.49% | -80.16% | -20.97% | 107/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 0.62% | -33.33% | -85.06% | 99/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 4.15% | 14.01% | -21.7% | 66/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 5.3% | -92.94% | 114.57% | 59/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 2.47% | -33.6% | 165.59% | 73/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.93% | 153.45% | -74.45% | 84/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 3.64% | 121.81% | -95.15% | 71/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 75.04% | 1591.85% | 1917.2% | 2/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 3.72% | 431.43% | 313.79% | 54/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -1.74% | 14.71% | 89.57% | 127/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -16.69% | 80.34% | -231.81% | 130/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -5.03% | -115.88% | -818.57% | 126/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.7% | 137.43% | 134.31% | 107/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -2.04% | -151.85% | 97.6% | 126/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -84.91% | -6436.57% | -3544.21% | 147/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -2.33% | -219.49% | -24.6% | 117/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -1.87% | -279.81% | -130.86% | 121/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.81% | -127.46% | -160.45% | 119/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.34% | -95.71% | -31.28% | 102/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 1.95% | -95.7% | 87.5% | 105/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.04% | -95.32% | -64.75% | 109/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.95% | -39.3% | -90.56% | 43/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 31.24% | 2% | -31.07% | 3/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 45.32% | 13633.33% | 104.05% | 1/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 22.21% | -59.05% | 357% | 3/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 4.86% | 2% | 2% | 14/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-03-31 | 0% | 100% | 2% | 100/159 | 2.44% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-12-31 | 0% | 100% | -100% | 118/159 | 7.16% | 奥赛康 | 35% | 行业排名> |
| 2017-09-30 | 0.33% | 100.19% | -99.39% | 93/159 | 8.3% | 奥赛康 | 28.15% | 行业排名> |
| 2017-06-30 | 54.24% | 149.41% | 4942.86% | 1/159 | 5.55% | 宏源药业 | 21.91% | 行业排名> |
| 2017-03-31 | -1.12% | -105.81% | 99.78% | 84/159 | 2.11% | 奥赛康 | 9.7% | 行业排名> |
| 2016-12-31 | -504.73% | -743.47% | -188.09% | 111/159 | 6.11% | 奥赛康 | 40.69% | 行业排名> |
| 2016-09-30 | -175.2% | -477.84% | -59.59% | 81/159 | 5.7% | 信立泰 | 25.93% | 行业排名> |
| 2016-06-30 | -109.78% | -716.82% | -669.1% | 90/159 | 3.56% | 昂利康 | 15.91% | 行业排名> |
| 2016-03-31 | 19.29% | 355.84% | 132.24% | 1/159 | 2.69% | 奥赛康 | 12.08% | 行业排名> |